Iovance Biotherapeutics, Inc. (IOVA) Financials

IOVA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 780.4 million 195.7 million
2023-09-30 852.3 million 178.3 million
2023-06-30 757.3 million 178.7 million
2023-03-31 824.8 million 157.9 million

IOVA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -87.5 million 14.4 million
2023-09-30 -87.7 million 15.8 million
2023-06-30 -103.5 million 16.7 million
2023-03-31 -105.5 million 15.7 million

IOVA Net Income

No data available :(

IOVA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 279.9 million - 74.9 million
2023-09-30 361.4 million - 78.5 million
2023-06-30 250.9 million 1.0 million 79.7 million
2023-03-31 626.3 million 1.0 million 82.2 million

IOVA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 256.0 million
2023-09-30 245.8 million
2023-06-30 224.5 million
2023-03-31 213.7 million

IOVA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 3.5 million 87.5 million 29.9 million -
2023-09-30 3.6 million 87.5 million 27.0 million -
2023-06-30 9.5 million 86.3 million 21.9 million -
2023-03-31 5.7 million 82.7 million 28.1 million -

IOVA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 482000 14.1 million
2023-09-30 469000 4.3 million
2023-06-30 238000 2.1 million
2023-03-31 - 5.7 million

IOVA

Price: $12.88

52 week price:
3.21
18.33

Earnings Per Share: -1.89 USD

P/E Ratio: -3.92

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 3.5 million

Ebitda: -22.1 million

Market Capitalization: 3.8 billion

Links: